| 1 | necrosis | 4,730 |
| 2 | suppressor | 575 |
| 3 | willebrand | 330 |
| 4 | 2-related | 33 |
| 5 | epithelium-derived | 14 |
| 6 | tumor-necrosis | 10 |
| 7 | nitricum | 9 |
| 8 | neovasculature | 8 |
| 9 | retargeting | 7 |
| 10 | monosomy-3 | 6 |
| 11 | patriciarum | 6 |
| 12 | lysate-pulsed | 4 |
| 13 | cell-bcg | 3 |
| 14 | enhanced/t2 | 3 |
| 15 | necrosis-alpha | 3 |
| 16 | p16-status | 3 |
| 17 | radio-resistance | 3 |
| 18 | shrinkages | 3 |
| 19 | hyodysenteriae-induced | 2 |
| 20 | ire-ablation | 2 |
| 21 | leprae-specific | 2 |
| 22 | necrosis-α | 2 |
| 23 | response/stabilisation | 2 |
| 24 | squamatus | 2 |
| 25 | subtilis/kg | 2 |
| 26 | tumour-necrosis | 2 |
| 27 | under-sampling | 2 |
| 28 | -recurrence | 1 |
| 29 | acid-inhibitable | 1 |
| 30 | activity-regulating | 1 |
| 31 | anoplodesmusanthracinus | 1 |
| 32 | antigen/hsp | 1 |
| 33 | area≥12.4 | 1 |
| 34 | associated-marker | 1 |
| 35 | b-cell-targeting | 1 |
| 36 | bio-banks | 1 |
| 37 | bucky | 1 |
| 38 | byopsy | 1 |
| 39 | calcineurin-nuclear | 1 |
| 40 | cell-stromal | 1 |
| 41 | cells. | 1 |
| 42 | cells/dc | 1 |
| 43 | ciampolini | 1 |
| 44 | d'onofrio | 1 |
| 45 | depression/dejection | 1 |
| 46 | dissemination/metastasis | 1 |
| 47 | endothelialgrowth | 1 |
| 48 | enucleoresection | 1 |
| 49 | eotaxin-3/th2-cytokine | 1 |
| 50 | escapement | 1 |
| 51 | exophthalmus-producing | 1 |
| 52 | growth/regression | 1 |
| 53 | growth/tumor | 1 |
| 54 | hpv-status | 1 |
| 55 | inflaction | 1 |
| 56 | jeremy | 1 |
| 57 | kruppel-like | 1 |
| 58 | leschenaultii | 1 |
| 59 | lysate- | 1 |
| 60 | markers-ovx1 | 1 |
| 61 | marre | 1 |
| 62 | megakaryocyte-active | 1 |
| 63 | microfoci | 1 |
| 64 | micromilieu | 1 |
| 65 | mikhailovskiy | 1 |
| 66 | models-pc3 | 1 |
| 67 | necrosis/atherosis | 1 |
| 68 | necroting | 1 |
| 69 | nercrosis | 1 |
| 70 | officinalis-and | 1 |
| 71 | p16-positivity | 1 |
| 72 | perfusion/permeability | 1 |
| 73 | phamae | 1 |
| 74 | polak | 1 |
| 75 | progression/dissemination | 1 |
| 76 | radioresponse | 1 |
| 77 | restorff | 1 |
| 78 | size-preoperative | 1 |
| 79 | size.compared | 1 |
| 80 | size/axillary | 1 |
| 81 | size≥18 | 1 |
| 82 | size≥4 | 1 |
| 83 | spinulosporum | 1 |
| 84 | stage/aggressiveness | 1 |
| 85 | stagesa | 1 |
| 86 | subrufescens-related | 1 |
| 87 | suppressor-related | 1 |
| 88 | type-specificity | 1 |
| 89 | varium/β-actin | 1 |
| 90 | vasorum-infected | 1 |
| 91 | viii/1587 | 1 |
| 92 | virus-chloramphenicol | 1 |
| 93 | virus-neu | 1 |
| 94 | virus-polyoma | 1 |
| 95 | volume/burden | 1 |
| 96 | wilbert | 1 |
| 97 | zablocki | 1 |
| 1 | -recurrence | 1 |
| 2 | 2-related | 33 |
| 3 | acid-inhibitable | 1 |
| 4 | activity-regulating | 1 |
| 5 | anoplodesmusanthracinus | 1 |
| 6 | antigen/hsp | 1 |
| 7 | area≥12.4 | 1 |
| 8 | associated-marker | 1 |
| 9 | b-cell-targeting | 1 |
| 10 | bio-banks | 1 |
| 11 | bucky | 1 |
| 12 | byopsy | 1 |
| 13 | calcineurin-nuclear | 1 |
| 14 | cell-bcg | 3 |
| 15 | cell-stromal | 1 |
| 16 | cells. | 1 |
| 17 | cells/dc | 1 |
| 18 | ciampolini | 1 |
| 19 | d'onofrio | 1 |
| 20 | depression/dejection | 1 |
| 21 | dissemination/metastasis | 1 |
| 22 | endothelialgrowth | 1 |
| 23 | enhanced/t2 | 3 |
| 24 | enucleoresection | 1 |
| 25 | eotaxin-3/th2-cytokine | 1 |
| 26 | epithelium-derived | 14 |
| 27 | escapement | 1 |
| 28 | exophthalmus-producing | 1 |
| 29 | growth/regression | 1 |
| 30 | growth/tumor | 1 |
| 31 | hpv-status | 1 |
| 32 | hyodysenteriae-induced | 2 |
| 33 | inflaction | 1 |
| 34 | ire-ablation | 2 |
| 35 | jeremy | 1 |
| 36 | kruppel-like | 1 |
| 37 | leprae-specific | 2 |
| 38 | leschenaultii | 1 |
| 39 | lysate- | 1 |
| 40 | lysate-pulsed | 4 |
| 41 | markers-ovx1 | 1 |
| 42 | marre | 1 |
| 43 | megakaryocyte-active | 1 |
| 44 | microfoci | 1 |
| 45 | micromilieu | 1 |
| 46 | mikhailovskiy | 1 |
| 47 | models-pc3 | 1 |
| 48 | monosomy-3 | 6 |
| 49 | necrosis | 4,730 |
| 50 | necrosis-alpha | 3 |
| 51 | necrosis-α | 2 |
| 52 | necrosis/atherosis | 1 |
| 53 | necroting | 1 |
| 54 | neovasculature | 8 |
| 55 | nercrosis | 1 |
| 56 | nitricum | 9 |
| 57 | officinalis-and | 1 |
| 58 | p16-positivity | 1 |
| 59 | p16-status | 3 |
| 60 | patriciarum | 6 |
| 61 | perfusion/permeability | 1 |
| 62 | phamae | 1 |
| 63 | polak | 1 |
| 64 | progression/dissemination | 1 |
| 65 | radio-resistance | 3 |
| 66 | radioresponse | 1 |
| 67 | response/stabilisation | 2 |
| 68 | restorff | 1 |
| 69 | retargeting | 7 |
| 70 | shrinkages | 3 |
| 71 | size-preoperative | 1 |
| 72 | size.compared | 1 |
| 73 | size/axillary | 1 |
| 74 | size≥18 | 1 |
| 75 | size≥4 | 1 |
| 76 | spinulosporum | 1 |
| 77 | squamatus | 2 |
| 78 | stage/aggressiveness | 1 |
| 79 | stagesa | 1 |
| 80 | subrufescens-related | 1 |
| 81 | subtilis/kg | 2 |
| 82 | suppressor | 575 |
| 83 | suppressor-related | 1 |
| 84 | tumor-necrosis | 10 |
| 85 | tumour-necrosis | 2 |
| 86 | type-specificity | 1 |
| 87 | under-sampling | 2 |
| 88 | varium/β-actin | 1 |
| 89 | vasorum-infected | 1 |
| 90 | viii/1587 | 1 |
| 91 | virus-chloramphenicol | 1 |
| 92 | virus-neu | 1 |
| 93 | virus-polyoma | 1 |
| 94 | volume/burden | 1 |
| 95 | wilbert | 1 |
| 96 | willebrand | 330 |
| 97 | zablocki | 1 |
| 1 | lysate- | 1 |
| 2 | cells. | 1 |
| 3 | markers-ovx1 | 1 |
| 4 | enhanced/t2 | 3 |
| 5 | monosomy-3 | 6 |
| 6 | models-pc3 | 1 |
| 7 | area≥12.4 | 1 |
| 8 | size≥4 | 1 |
| 9 | viii/1587 | 1 |
| 10 | size≥18 | 1 |
| 11 | necrosis-alpha | 3 |
| 12 | virus-polyoma | 1 |
| 13 | stagesa | 1 |
| 14 | cells/dc | 1 |
| 15 | leprae-specific | 2 |
| 16 | hyodysenteriae-induced | 2 |
| 17 | size.compared | 1 |
| 18 | lysate-pulsed | 4 |
| 19 | 2-related | 33 |
| 20 | suppressor-related | 1 |
| 21 | subrufescens-related | 1 |
| 22 | vasorum-infected | 1 |
| 23 | epithelium-derived | 14 |
| 24 | officinalis-and | 1 |
| 25 | willebrand | 330 |
| 26 | phamae | 1 |
| 27 | radio-resistance | 3 |
| 28 | -recurrence | 1 |
| 29 | kruppel-like | 1 |
| 30 | acid-inhibitable | 1 |
| 31 | eotaxin-3/th2-cytokine | 1 |
| 32 | marre | 1 |
| 33 | neovasculature | 8 |
| 34 | radioresponse | 1 |
| 35 | size-preoperative | 1 |
| 36 | megakaryocyte-active | 1 |
| 37 | restorff | 1 |
| 38 | cell-bcg | 3 |
| 39 | subtilis/kg | 2 |
| 40 | exophthalmus-producing | 1 |
| 41 | under-sampling | 2 |
| 42 | activity-regulating | 1 |
| 43 | b-cell-targeting | 1 |
| 44 | retargeting | 7 |
| 45 | necroting | 1 |
| 46 | endothelialgrowth | 1 |
| 47 | microfoci | 1 |
| 48 | leschenaultii | 1 |
| 49 | zablocki | 1 |
| 50 | ciampolini | 1 |
| 51 | polak | 1 |
| 52 | cell-stromal | 1 |
| 53 | virus-chloramphenicol | 1 |
| 54 | nitricum | 9 |
| 55 | patriciarum | 6 |
| 56 | spinulosporum | 1 |
| 57 | volume/burden | 1 |
| 58 | varium/β-actin | 1 |
| 59 | growth/regression | 1 |
| 60 | ire-ablation | 2 |
| 61 | progression/dissemination | 1 |
| 62 | response/stabilisation | 2 |
| 63 | inflaction | 1 |
| 64 | depression/dejection | 1 |
| 65 | enucleoresection | 1 |
| 66 | d'onofrio | 1 |
| 67 | antigen/hsp | 1 |
| 68 | calcineurin-nuclear | 1 |
| 69 | associated-marker | 1 |
| 70 | growth/tumor | 1 |
| 71 | suppressor | 575 |
| 72 | shrinkages | 3 |
| 73 | dissemination/metastasis | 1 |
| 74 | necrosis | 4,730 |
| 75 | tumor-necrosis | 10 |
| 76 | tumour-necrosis | 2 |
| 77 | nercrosis | 1 |
| 78 | necrosis/atherosis | 1 |
| 79 | bio-banks | 1 |
| 80 | stage/aggressiveness | 1 |
| 81 | anoplodesmusanthracinus | 1 |
| 82 | squamatus | 2 |
| 83 | p16-status | 3 |
| 84 | hpv-status | 1 |
| 85 | escapement | 1 |
| 86 | wilbert | 1 |
| 87 | micromilieu | 1 |
| 88 | virus-neu | 1 |
| 89 | mikhailovskiy | 1 |
| 90 | bucky | 1 |
| 91 | jeremy | 1 |
| 92 | size/axillary | 1 |
| 93 | byopsy | 1 |
| 94 | type-specificity | 1 |
| 95 | perfusion/permeability | 1 |
| 96 | p16-positivity | 1 |
| 97 | necrosis-α | 2 |